DrugPatentWatch Database Preview
DUOPA Drug Profile
Email this page to a colleague
» See Plans and PricingWhich patents cover Duopa, and when can generic versions of Duopa launch?
Duopa is a drug marketed by Abbvie Inc and is included in one NDA.
The generic ingredient in DUOPA is carbidopa; levodopa. There are eighteen drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the carbidopa; levodopa profile page.
Summary for DUOPA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 3 |
| Patent Applications: | 32 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for DUOPA |
| DailyMed Link: | DUOPA at DailyMed |
Pharmacology for DUOPA
| Drug Class | Aromatic Amino Acid |
US Patents and Regulatory Information for DUOPA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie Inc | DUOPA | carbidopa; levodopa | SUSPENSION;ENTERAL | 203952-001 | Jan 9, 2015 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
